These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2464774)

  • 1. A dose escalation study of ORG 10172 (low molecular weight heparinoid) in stroke.
    Biller J; Massey EW; Marler JR; Adams HP; Davis JN; Bruno A; Henriksen RA; Linhardt RJ; Goldstein LB; Alberts M
    Neurology; 1989 Feb; 39(2 Pt 1):262-5. PubMed ID: 2464774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Large-dose infusions of heparinoid ORG 10172 in ischemic stroke.
    Massey EW; Biller J; Davis JN; Adams HP; Marler JR; Goldstein LB; Alberts M; Bruno A
    Stroke; 1990 Sep; 21(9):1289-92. PubMed ID: 2396265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of a low molecular weight heparinoid in chronic intermittent haemodialysis.
    Henny CP; ten Cate H; Surachno S; Stevens P; Büller HR; den Hartog M; ten Cate JW
    Thromb Haemost; 1985 Aug; 54(2):460-2. PubMed ID: 2417351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind randomised trial of Org 10172 low-molecular-weight heparinoid in prevention of deep-vein thrombosis in thrombotic stroke.
    Turpie AG; Levine MN; Hirsh J; Carter CJ; Jay RM; Powers PJ; Andrew M; Magnani HN; Hull RD; Gent M
    Lancet; 1987 Mar; 1(8532):523-6. PubMed ID: 2434815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight heparinoid, ORG 10172 (danaparoid), and outcome after acute ischemic stroke: a randomized controlled trial. The Publications Committee for the Trial of ORG 10172 in Acute Stroke Treatment (TOAST) Investigators.
    JAMA; 1998 Apr 22-29; 279(16):1265-72. PubMed ID: 9565006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A low-molecular-weight heparinoid compared with unfractionated heparin in the prevention of deep vein thrombosis in patients with acute ischemic stroke. A randomized, double-blind study.
    Turpie AG; Gent M; Côte R; Levine MN; Ginsberg JS; Powers PJ; Leclerc J; Geerts W; Jay R; Neemeh J
    Ann Intern Med; 1992 Sep; 117(5):353-7. PubMed ID: 1503326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and pharmacokinetics of the low molecular weight heparinoid Org 10172 administered to healthy elderly volunteers.
    Stiekema JC; Wijnand HP; Van Dinther TG; Moelker HC; Dawes J; Vinchenzo A; Toeberich H
    Br J Clin Pharmacol; 1989 Jan; 27(1):39-48. PubMed ID: 2468354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Parenteral anticoagulation with the heparinoid Lomoparan (Org 10172) in patients with heparin induced thrombocytopenia and thrombosis.
    Ortel TL; Gockerman JP; Califf RM; McCann RL; O'Connor CM; Metzler DM; Greenberg CS
    Thromb Haemost; 1992 Mar; 67(3):292-6. PubMed ID: 1379384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies of Org 10172 in patients with acute ischemic stroke. TOAST Study Group.
    Adams HP; Woolson RF; Biller J; Clarke W
    Haemostasis; 1992; 22(2):99-103. PubMed ID: 1379970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of a heparinoid in patients with hemorrhagic stroke and thromboembolic disease.
    Ten Cate H; Henny CP; Büller HR; Ten Cate JW; Magnani HN
    Ann Neurol; 1984 Mar; 15(3):268-70. PubMed ID: 6721448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A new low molecular weight heparinoid Org 10172 as anticoagulant in hemodialysis.
    Von Bonsdorff M; Stiekema J; Harjanne A; Alapiessa U
    Int J Artif Organs; 1990 Feb; 13(2):103-8. PubMed ID: 2347652
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastrointestinal blood loss in haemodialysis patients during use of a low-molecular-weight heparinoid anticoagulant.
    Frei U; Wilks MF; Boehmer S; Crisp-Lindgren N; Schwarzrock R; Stiekema JC; Koch KM
    Nephrol Dial Transplant; 1988; 3(4):435-9. PubMed ID: 2459635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized blind study comparing standard heparin and a new low molecular weight heparinoid in cardiopulmonary bypass surgery in dogs.
    Henny CP; Ten Cate H; Ten Cate JW; Moulijn AC; Sie TH; Warren P; Büller HR
    J Lab Clin Med; 1985 Aug; 106(2):187-96. PubMed ID: 4020247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of Org 10172, an antithrombotic heparinoid, on urinary blood loss after transurethral prostatectomy.
    Gallus A; Murphy W; Nacey J; Morris M; Sutherland P; Marshall V; Magnani H
    Thromb Res; 1989 Oct; 56(2):229-38. PubMed ID: 2482549
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet aggregation in response to four low molecular weight heparins and the heparinoid ORG 10172 in patients with heparin-induced thrombocytopenia.
    Keeling DM; Richards EM; Baglin TP
    Br J Haematol; 1994 Feb; 86(2):425-6. PubMed ID: 7515270
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low-molecular-weight heparinoid compared with warfarin for prophylaxis of deep-vein thrombosis in patients who are operated on for fracture of the hip. A prospective, randomized trial.
    Gerhart TN; Yett HS; Robertson LK; Lee MA; Smith M; Salzman EW
    J Bone Joint Surg Am; 1991 Apr; 73(4):494-502. PubMed ID: 1707413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The anticoagulant effect of heparinoid Org 10172 during haemodialysis: an objective assessment.
    Ireland H; Lane DA; Flynn A; Anastassiades E; Curtis JR
    Thromb Haemost; 1986 Apr; 55(2):271-5. PubMed ID: 3715791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction study between Org 10172, a low molecular weight heparinoid, and acetylsalicylic acid in healthy male volunteers.
    de Boer A; Danhof M; Cohen AF; Magnani HN; Breimer DD
    Thromb Haemost; 1991 Aug; 66(2):202-7. PubMed ID: 1722918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparin-associated thrombocytopenia type II in a patient with end-stage renal disease: successful anticoagulation with the low-molecular-weight heparinoid Org 10172 during haemodialysis.
    Greinacher A; Philippen KH; Kemkes-Matthes B; Möckl M; Mueller-Eckhardt C; Schaefer K
    Nephrol Dial Transplant; 1993; 8(10):1176-7. PubMed ID: 7505906
    [No Abstract]   [Full Text] [Related]  

  • 20. Prevention of deep vein thrombosis following total hip replacement by low molecular weight heparinoid.
    Hoek JA; Nurmohamed MT; Hamelynck KJ; Marti RK; Knipscheer HC; ten Cate H; Büller HR; Magnani HN; ten Cate JW
    Thromb Haemost; 1992 Jan; 67(1):28-32. PubMed ID: 1615479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.